Table 3

Degree of clinical improvement stratified by shared epitope status

Treatment groupShared epitope statusChange in tender jointsChange in swollen joints
MethotrexateNegative−19.5 (1.4)−19.2 (10.1)
}p=0.95}p=0.97
All three drugsNegative−20.0 (21.0)−19.4 (15.1)
MethotrexatePositive−12.5 (14.7)−15.0 (15.4)
}p=0.007}p=0.019
All three drugsPositive−23.4 (9.1)−25.9 (11.1)
  • Values are mean (SD) of the change in scores from start of treatment until study completion.